Related references
Note: Only part of the references are listed.Zonisamide: Aspects in neuroprotection
Thomas W. Roesler et al.
EXPERIMENTAL NEUROLOGY (2010)
Hyperoxic exposure leads to cell death in the developing brain
Uluc Yis et al.
BRAIN & DEVELOPMENT (2008)
Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety
Sanjeev V. Kothare et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Hyperoxia causes maturation-dependent cell death in the developing white matter
Bettina Gerstner et al.
JOURNAL OF NEUROSCIENCE (2008)
Zonisamide in the treatment of painful diabetic neuropathy: A randomized, double-blind, placebo-controlled pilot study
A Atli et al.
PAIN MEDICINE (2005)
Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain
U Felderhoff-Mueser et al.
ANNALS OF NEUROLOGY (2005)
Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease
M Murata
CURRENT PHARMACEUTICAL DESIGN (2004)
Oxygen causes cell death in the developing brain
U Felderhoff-Mueser et al.
NEUROBIOLOGY OF DISEASE (2004)
Open-label zonisamide for refractory migraine
ME Drake et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Hyperoxia causes inducible nitric oxide synthase-mediated cellular damage to the immature rat brain
T Hoehn et al.
PEDIATRIC RESEARCH (2003)
Cytokines and acute neurodegeneration
SM Allan et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Zonisamide reduces the increase in 8-hydroxy-2 '-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats
M Komatsu et al.
EPILEPSIA (2000)
Share Paper
